Send us a textHappy Canada day everyone! Today’s guest is Jachym Fibir, Co-Founder and CEO of April19 Discovery. Their innovative AI driven approach uses state-of-the-art computational chemistry to design and develop the next generation of psychedelic-inspired compounds to treat neurodegenerative indications and increase longevity. Listen as we discuss stimulating neuroplasticity, the future of psychedelic medicine and creating non psychedelic psychedelics.Pluggables:Jachym's companySpannr article on dementia treatmentsSupport the showAs always, if you like what you hear, please leave a review on iTunes. If you want more great content as it releases, subscribe where ever you listen to great podcasts and follow on Instagram for cool updates and episode previews.

Ver todos los episodios